• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Research Articles Abstract - 2010 Issues Archive

Giuseppe

Emeritus
Research Articles Abstracts - January 9, 2010 Issue

Research Articles Abstracts - January 9, 2010 Issue

This week, abstracts have been posted individually with a reference code (RA-10..)

Source Abstract coded RA-1001 to RA-1010 are available following this LINK.


Abstracts List:



  1. Fowler AW.
    • A/H1N1 flu pandemic. Fever as nature's engine?
    • BMJ. 2009;339:b3874.
  2. Zarocostas J.
    • Too early to declare H1N1 swine flu pandemic over, says WHO chief.
    • BMJ. 2009;339:b5681.
  3. Scansen KA, Bonsu BK, Stoner E, Mack K, et al.
    • Comparison of polyurethane foam vs. nylon flocked swab collection of anterior nares secretions on performance of a rapid influenza virus antigen test in a pediatric emergency department.
    • J Clin Microbiol. 2010.
  4. Mishin VP, Watanabe M, Taylor G, Devincenzo J, et al.
    • N-Linked Glycan at Residue 523 of Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Masks a Second Receptor-Binding Site.
    • J Virol. 2010.
  5. Norton EB, Clements JD, Voss TG, Cardenas-Freytag L, et al.
    • Prophylactic Administration of Bacterially Derived Immunomodulators Improves the Outcome of Influenza Infection in a Murine Model.
    • J Virol. 2010.
  6. Ueda M, Daidoji T, Du A, Yang CS, et al.
    • Highly Pathogenic H5N1 Avian Influenza Virus Induces Extracellular Ca2+ Influx, Leading to Apoptosis in Avian Cells.
    • J Virol. 2010.
  7. Uyeki TM, Sharma A, Branda JA.
    • Case records of the Massachusetts General Hospital. Case 40-2009. A 29-year-old man with Fever and respiratory failure.
    • N Engl J Med. 2009;361:2558-69.
  8. Cate TR, Rayford Y, Nino D, Winokur P, et al.
    • A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
    • Vaccine. 2009.
  9. Busquets N, Alba A, Napp S, Sanchez A, et al.
    • Influenza A virus subtypes in wild birds in North-Eastern Spain (Catalonia).
    • Virus Res. 2009.
  10. Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, et al.
    • CS-8958 (laninamivir prodrug), a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
    • Antimicrob Agents Chemother. 2010.
-
-----
 
Research Abstracts - January 16, 2010 Issue

Research Abstracts - January 16, 2010 Issue

Research Abstracts - January 16, 2010 Issue

Research Abstracts - January 16, 2010 Issue

[Source Abstracts: LINK. EDITED.]

Contents:

RA-1011. ZHIQIANG W, Yaowu Y, Fan Y, Jian Y, et al.
Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus.
Antiviral Res. 2010.
ABSTRACT available

RA-1012. MONTALVO-CORRAL M, Hernandez J.
Genetic analysis of avian influenza virus from migratory waterfowl in Mexico.
Arch Virol. 2010;155:97-101.
ABSTRACT available

RA-1013. MATSUI M, Kohyama S, Suda T, Yokoyama S, et al.
A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
Biochem Biophys Res Commun. 2010.
ABSTRACT available

RA-1014. SHAPIRA SD, Gat-Viks I, Shum BO, Dricot A, et al.
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection.
Cell. 2009;139:1255-67.
ABSTRACT available

RA-1015. BRASS AL, Huang IC, Benita Y, John SP, et al.
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Cell. 2009;139:1243-54.
ABSTRACT available

RA-1016. COHEN SA, Klassen AC, Ahmed S, Agree EM, et al.
Trends for influenza and pneumonia hospitalization in the older population: age, period, and cohort effects.
Epidemiol Infect. 2010.
ABSTRACT available

RA-1017. CHIDLOW G, Harnett G, Williams S, Levy A, et al.
Duplex real-time RT-PCR assays for the rapid detection and identification of pandemic (H1N1) 2009 and seasonal influenza viruses A/H1, A/H3 and B.
J Clin Microbiol. 2010.
ABSTRACT available

RA-1018. KUBO T, Agoh M, Mai LQ, Fukushima K, et al.
Development of reverse transcription-loop-mediated isothermal amplification assay for pandemic (H1N1) 2009 virus as a novel molecular based testing for pandemic influenza even in resource limited settings.
J Clin Microbiol. 2010.
ABSTRACT available

RA-1019. MIYOSHI-AKIYAMA T, Narahara K, Mori S, Kitajima H, et al.
Development of an immunochromatographic assay specifically detecting pandemic H1N1 (2009) influenza virus.
J Clin Microbiol. 2010.
ABSTRACT available

RA-1020. GOODWIN R, Haque S, Neto F, Myers L, et al.
Initial behavioural and attitudinal responses to influenza A, H1N1 ('swine flu').
J Epidemiol Community Health. 2010;64:182.

RA-1021. READ EK, Digard P.
Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export.
J Gen Virol. 2010.
ABSTRACT available

RA-1022. ZAVITZ CC, Bauer CM, Gaschler GJ, Fraser KM, et al.
Dysregulated Macrophage-Inflammatory Protein-2 Expression Drives Illness in Bacterial Superinfection of Influenza.
J Immunol. 2010.
ABSTRACT available

RA-1023. THOMAS PG, Brown SA, Morris MY, Yue W, et al.
Physiological Numbers of CD4+ T Cells Generate Weak Recall Responses Following Influenza Virus Challenge.
J Immunol. 2010.
ABSTRACT available

RA-1024. LI Y, Chan EY, Li J, Ni C, et al.
MicroRNA Expression and Virulence in Pandemic Influenza Virus Infected Mice.
J Virol. 2010.
ABSTRACT available

RA-1025. PRABAKARAN M, Madhan S, Prabhu N, Qiang J, et al.
Gastrointestinal delivery of baculovirus displaying influenza hemagglutinin protects mice against heterologous H5N1 infection.
J Virol. 2010.
ABSTRACT available

RA-1026. SUPHAPHIPHAT P, Keiner B, Trusheim H, Crotta S, et al.
Human RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus in Canine Cells.
J Virol. 2010.
ABSTRACT available

RA-1027. FUSARO A, Nelson MI, Joannis T, Bertolotti L, et al.
Evolutionary Dynamics of Multiple Sublineages of H5N1 Influenza Viruses in Nigeria, 2006-2008.
J Virol. 2010.
ABSTRACT available

RA-1028. GE X, Tan V, Bollyky PL, Standifer NE, et al.
Assessment Of Seasonal Influenza A Specific CD4 T Cell Responses To 2009 Pandemic H1N1 Swine-Origin Influenza A Virus.
J Virol. 2010.
ABSTRACT available

RA-1029. Outbreak of 2009 pandemic influenza A (H1N1) at a school - Hawaii, May 2009.
MMWR Morb Mortal Wkly Rep. 2010;58:1440-4.
ABSTRACT available

RA-1030. Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009.
MMWR Morb Mortal Wkly Rep. 2010;58:1436-40.
ABSTRACT available

RA-1031. NARAYAN KM, del Rio C.
Comparative efficacy of influenza vaccines.
N Engl J Med. 2010;362:179-80.

RA-1032. CHEN Y, Wu J, Yi QL.
Reduced risk of hospitalization associated with influenza vaccination in Canada.
Vaccine. 2010.
ABSTRACT available

RA-1033. BRAHMAKSHATRIYA VR, Lupiani B, Reddy SM.
Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
Vaccine. 2010.
ABSTRACT available

RA-1034. JOO HM, He Y, Sundararajan A, Huan L, et al.
Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination.
Vaccine. 2010.
ABSTRACT available

RA-1035. YOO BK, Szilagyi PG, Schaffer SJ, Humiston SG, et al.
Cost of universal influenza vaccination of children in pediatric practices.
Pediatrics. 2009;124 Suppl 5:S499-506.
ABSTRACT available

Journals Screened:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res

-
------
 
Research Articles Abstracts - January 22, 2009 Issue

Research Articles Abstracts - January 22, 2009 Issue

Research Articles Abstracts - January 22, 2009 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - January 22 2009 Issue



  1. Granwehr B.
    • ACP Journal Club. A 15-microg dose of unadjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in healthy adults within 21 days.
    • Ann Intern Med. 2010;152:JC1-9.
    • RA-1036
  2. Granwehr B.
    • ACP Journal Club. One or two 7.5-microg doses of MF59-adjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in adults within 21 days.
    • Ann Intern Med. 2010;152:JC1-8.
    • RA-1037
  3. Correia V, Andrade HR, Santos LA, Lackenby A, et al.
    • Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons.
    • Antiviral Res. 2010.
    • Abstract available
    • RA-1038
  4. Watson R.
    • Politician accuses drug companies of overplaying dangers of H1N1.
    • BMJ. 2010;340:c198.
    • RA-1039
  5. Vargas-Parada L.
    • H1N1: a Mexican perspective.
    • Cell. 2009;139:1203-5.
    • Abstract available
    • RA-1040
  6. Jonges M, Liu WM, van der Vries E, Jacobi R, et al.
    • Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling.
    • J Clin Microbiol. 2010.
    • Abstract available
    • RA-1041
  7. Mays JW, Bailey MT, Hunzeker JT, Powell ND, et al.
    • Influenza Virus-Specific Immunological Memory Is Enhanced by Repeated Social Defeat.
    • J Immunol. 2010.
    • Abstract available
    • RA-1042
  8. Small CL, Shaler CR, McCormick S, Jeyanathan M, et al.
    • Influenza Infection Leads to Increased Susceptibility to Subsequent Bacterial Superinfection by Impairing NK Cell Responses in the Lung.
    • J Immunol. 2010.
    • Abstract available
    • RA-1043
  9. Aiello AE, Murray GF, Perez V, Coulborn RM, et al.
    • Mask Use, Hand Hygiene, and Seasonal Influenza-Like Illness among Young Adults: A Randomized Intervention Trial.
    • J Infect Dis. 2010.
    • Abstract available
    • RA-1044
  10. Daniels TL, Talbot TR.
    • Unmasking the Confusion of Respiratory Protection to Prevent Influenza-Like Illness in Crowded Community Settings.
    • J Infect Dis. 2010.
    • RA-1045
  11. Larson HJ, Heymann DL.
    • Public health response to influenza A(H1N1) as an opportunity to build public trust.
    • JAMA. 2010;303:271-2.
    • RA-1046
  12. Linder J.
    • Comparative efficacy of influenza vaccines.
    • N Engl J Med. 2010;362:180.
    • RA-1047
  13. Goldstein E, Dushoff J, Ma J, Plotkin JB, et al.
    • Reconstructing influenza incidence by deconvolution of daily mortality time series.
    • Proc Natl Acad Sci U S A. 2009;106:21825-9.
    • Abstract available
    • RA-1048
  14. Kiso M, Takahashi K, Sakai-Tagawa Y, Shinya K, et al.
    • T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.
    • Proc Natl Acad Sci U S A. 2010;107:882-7.
    • Abstract available
    • RA-1049
  15. Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, et al.
    • An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    • Vaccine. 2010.
    • Abstract available
    • RA-1050
-
-----
 
Research Articles Abstracts - January 30 2010 Issue

Research Articles Abstracts - January 30 2010 Issue

Research Articles Abstracts - January 30 2010 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - January 30 2010 Issue



  1. HOULIHAN CF, Patel S, Price DA, Valappil M, et al.
    • A/H1N1 flu pandemic. Life threatening infections labelled swine flu.
    • BMJ. 2010;340:c137.
  2. MARYON-DAVIS AR.
    • The truth about Tamiflu? Data access is matter of trust.
    • BMJ. 2010;340:c134.
  3. EAGEL BA.
    • The truth about Tamiflu? Zanamivir should be inhaled, not nebulised.
    • BMJ. 2010;340:c131.
  4. WEBER JT, Nicoll A, Bridges CB, Ciancio BC, et al.
    • The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu.
    • BMJ. 2010;340:c130.
  5. WHITE C.
    • Government is in talks with GSK to offload surplus swine flu vaccine.
    • BMJ. 2010;340:c170.
  6. CEYHAN M, Yildirim I, Ferraris O, Bouscambert-Duchamp M, et al.
    • Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic.
    • Epidemiol Infect. 2010.
    • ABSTRACT available
  7. COWLING BJ, Zhou Y, Ip DK, Leung GM, et al.
    • Face masks to prevent transmission of influenza virus: a systematic review.
    • Epidemiol Infect. 2010.
    • ABSTRACT available
  8. BIERE B, Bauer B, Schweiger B.
    • Distinction of Influenza B virus lineages Yamagata and Victoria by real-time PCR.
    • J Clin Microbiol. 2010.
    • ABSTRACT available
  9. PANDA A, Qian F, Mohanty S, van Duin D, et al.
    • Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response.
    • J Immunol. 2010.
    • ABSTRACT available
  10. LANDAVERDE JM, Danovaro-Holliday MC, Trumbo SP, Pacis-Tirso CL, et al.
    • Guillain-Barre Syndrome in Children Aged <15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) Pandemic.
    • J Infect Dis. 2010.
    • ABSTRACT available
  11. BAZ M, Abed Y, Simon P, Hamelin ME, et al.
    • Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses.
    • J Infect Dis. 2010.
    • ABSTRACT available
  12. GUBAREVA LV, Fry AM.
    • Current Challenges in the Risk Assessment of Neuraminidase Inhibitor-Resistant Influenza Viruses.
    • J Infect Dis. 2010.
  13. UPHAM JP, Pickett D, Irimura T, Anders EM, et al.
    • Macrophage Receptors for Influenza A Virus: Role of the Macrophage Galactose-type Lectin and Mannose Receptor in Viral Entry.
    • J Virol. 2010.
    • ABSTRACT available
  14. MILLER E, Hoschler K, Hardelid P, Stanford E, et al.
    • Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    • Lancet. 2010.
    • ABSTRACT available
  15. REED C, Katz JM.
    • Serological surveys for 2009 pandemic influenza A H1N1.
    • Lancet. 2010.
  16. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:44-8.
    • ABSTRACT available
  17. Update: influenza activity --- United States, August 30, 2009-January 9, 2010.
    • MMWR Morb Mortal Wkly Rep. 2010;59:38-43.
    • ABSTRACT available
  18. AMENDOLA A, Pariani E, Vigano A, Erba P, et al.
    • Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza.
    • Vaccine. 2010.
    • ABSTRACT available
  19. BAGUELIN M, Hoek AJ, Jit M, Flasche S, et al.
    • Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation.
    • Vaccine. 2010.
    • ABSTRACT available
  20. BURIONI R, Canducci F, Mancini N, Clementi N, et al.
    • Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).
    • Virology. 2010.
    • ABSTRACT available
  21. BUNDY DG, Strouse JJ, Casella JF, Miller MR, et al.
    • Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell Disease.
    • Pediatrics. 2010.
    • ABSTRACT available

We have screened the following journals for you:

  • Am J Med
  • Ann Intern Med
  • Antimicrob Agents Chemother
  • Antiviral Res
  • Arch Intern Med
  • Arch Virol
  • Biochem Biophys Res Commun
  • Biochem Soc Trans
  • Biochemistry
  • BMJ
  • Cell
  • Clin Diagn Lab Immunol
  • Commun Dis Rep CDR Wkly
  • Drug Saf
  • Drugs
  • Epidemiol Infect
  • Eur J Epidemiol
  • J Clin Microbiol
  • J Epidemiol Community Health
  • J Exp Med
  • J Gen Virol
  • J Immunol
  • J Infect
  • J Infect Dis
  • J Virol
  • J Virol Methods
  • JAMA
  • Lancet
  • MMWR Morb Mortal Wkly Rep
  • N Engl J Med
  • Pediatrics
  • Proc Natl Acad Sci U S A
  • Vaccine
  • Virology
  • Virus Res
-
------
 
Research Articles Abstracts - February 5, 2010 Issue

Research Articles Abstracts - February 5, 2010 Issue

Research Articles Abstracts - February 5, 2010 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - February 5, 2010 Issue



  1. Shan S, Ellis T, Fenwick S, Edwards J, et al.
    • Biological and genetic characterization of a low-pathogenicity avian influenza H6N2 virus originating from a healthy Eurasian coot.
    • Arch Virol. 2010.
    • Abstract available
  2. Ahmed SS, Ersboll AK, Biswas PK, Christensen JP, et al.
    • The space-time clustering of highly pathogenic avian influenza (HPAI) H5N1 outbreaks in Bangladesh.
    • Epidemiol Infect. 2010.
    • Abstract available
  3. Zaraket H, Saito R, Suzuki Y, Baranovich T, et al.
    • The Genetic Makeup of Amantadine-Resistant and Oseltamivir-Resistant Human Influenza A/H1N1 Viruses.
    • J Clin Microbiol. 2010.
    • Abstract available
  4. Lu X, Masic A, Li Y, Shin Y, et al.
    • The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1.
    • J Gen Virol. 2010.
    • Abstract available
  5. Herfst S, Chutinimitkul S, Ye J, de Wit E, et al.
    • Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission.
    • J Virol. 2010.
    • Abstract available
  6. Huber VC, Peltola V, McCullers JA.
    • Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications.
    • J Virol. 2010.
    • Abstract available
  7. Saenz RA, Quinlivan M, Elton D, Macrae S, et al.
    • Dynamics of Infection and Pathology in Influenza.
    • J Virol. 2010.
    • Abstract available
  8. Achdout H, Segman T, Hirsh S, Glasner A, et al.
    • Killing of avian and swine influenza by Natural Killer cells.
    • J Virol. 2010.
    • Abstract available
  9. Schwahn AB, Wong JW, Downard KM.
    • Typing of Human and Animal Strains of Influenza Virus, with Conserved Signature Peptides of Matrix M1 Protein, by High Resolution Mass Spectrometry.
    • J Virol Methods. 2010.
    • Abstract available
  10. Chander Y, Jindal N, Stallknecht DE, Goyal SM, et al.
    • Full length sequencing of all nine subtypes of the neuraminidase gene of influenza A viruses using subtype specific primer sets.
    • J Virol Methods. 2010.
    • Abstract available
  11. Gautret P, Parola P, Brouqui P.
    • Risk factors for H1N1 influenza complications in 2009 Hajj pilgrims.
    • Lancet. 2010;375:199-200.
  12. Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents - three states, 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:74-7.
    • Abstract available
  13. Miyaki C, Quintilio W, Miyaji EN, Botosso VF, et al.
    • Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
    • Vaccine. 2010.
    • Abstract available
  14. Schwarzinger M, Verger P, Guerville MA, Aubry C, et al.
    • Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: A missed opportunity to increase vaccination uptakes in the general public?
    • Vaccine. 2010.
    • Abstract available
  15. Aranda-Romo S, Comas-Garcia A, Garcia-Sepulveda CA, Hernandez-Salinas AE, et al.
    • Effect of an immunization program on seasonal influenza hospitalizations in Mexican children.
    • Vaccine. 2010.
    • Abstract available
  16. Smith LR, Wloch MK, Ye M, Reyes LR, et al.
    • Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    • Vaccine. 2010.
    • Abstract available
  17. Wu J, Zhang F, Fang F, Chang H, et al.
    • Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
    • Vaccine. 2010.
    • Abstract available
  18. Desante JE, Caplan A, Shofer F, Behrman AJ, et al.
    • Physician attitudes towards influenza immunization and vaccine mandates.
    • Vaccine. 2010.
    • Abstract available
  19. Souza AR, Braga JA, de Paiva TM, Loggetto SR, et al.
    • Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.
    • Vaccine. 2010;28:1117-20.
    • Abstract available
  20. Kwong JC, Ge H, Rosella LC, Guan J, et al.
    • School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: An ecological study.
    • Vaccine. 2010.
    • Abstract available
  21. Bukreyev AA, Dinapoli JM, Yang L, Murphy BR, et al.
    • Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic.
    • Virology. 2010.
    • Abstract available
  22. Driskell EA, Jones CA, Stallknecht DE, Howerth EW, et al.
    • Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection.
    • Virology. 2010.
    • Abstract available
  23. Singh S, Briles WE, Lupiani B, Collisson EW, et al.
    • Avian influenza viral nucleocapsid and hemagglutinin proteins induce chicken CD8(+) memory T lymphocytes.
    • Virology. 2010.
    • Abstract available
-
-----
 
Research Articles Abstracts - February 12 2010 Issue

Research Articles Abstracts - February 12 2010 Issue

Research Articles Abstracts - February 12 2010 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - February 12 2010 Issue


  1. Leonardi GP, Mitrache I, Pigal A, Freedman L, et al.
    • PUBLIC HOSPITAL-BASED LABORATORY EXPERIENCE DURING AN OUTBREAK OF PANDEMIC INFLUENZA A (H1N1) VIRUS.
    • J Clin Microbiol. 2010.
    • Abstract available
  2. Furuya Y, Regner M, Lobigs M, Koskinen A, et al.
    • The effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.
    • J Gen Virol. 2010.
    • Articles Abstract available
  3. Bicanic T, Solomon AW, Karunaharan N, Chua F, et al.
    • Positive predictive value of the UK clinical case definition for H1N1/09 ('swine') influenza.
    • J Infect. 2010.
    • Related Articles
  4. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, et al.
    • 2009 H1n1 Influenza Infection In Cancer Patients And Hematopoietic Stem Cell Transplant Recipients.
    • J Infect. 2010.
    • Abstract available
  5. Matsui T, Hakozaki Y, Suzuki S, Usui T, et al.
    • A Novel Screening Method for Influenza Patients using a Newly Developed Non-contact Screening System.
    • J Infect. 2010.
    • Abstract available
  6. Epstein MA, Reynaldo S, El-Amin AN.
    • Is smoking a risk factor for influenza hospitalization and death?
    • J Infect Dis. 2010;201:794-5.
  7. Mendelson M, Tekoah Y, Zilka A, Gershoni-Yahalom O, et al.
    • NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.
    • J Virol. 2010.
    • Abstract available
  8. Chen Y, Xu F, Gui X, Yang K, et al.
    • A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009.
    • J Virol Methods. 2010.
    • Abstract available
  9. Zhao C, Hsiang TY, Kuo RL, Krug RM, et al.
    • ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells.
    • Proc Natl Acad Sci U S A. 2010;107:2253-8.
    • Abstract available
  10. Hale BG, Kerry PS, Jackson D, Precious BL, et al.
    • Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein.
    • Proc Natl Acad Sci U S A. 2010;107:1954-9.
    • Abstract available
  11. Wu JT, Lee CK, Cowling BJ, Yuen KY, et al.
    • Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic.
    • Proc Natl Acad Sci U S A. 2010.
    • Abstract available
  12. Schaap-Nutt A, Scull MA, Schmidt AC, Murphy BR, et al.
    • Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.
    • Vaccine. 2010.
    • Abstract available
  13. Krashias G, Simon K, Wegmann F, Kok WL, et al.
    • Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
    • Vaccine. 2010.
    • Abstract available
  14. Vincent AL, Ciacci-Zanella JR, Lorusso A, Gauger PC, et al.
    • Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
    • Vaccine. 2010.
    • Abstract available
-
------
 
Research Articles Abstracts - February 19 2010 Issue

Research Articles Abstracts - February 19 2010 Issue

Research Articles Abstracts - February 19 2010 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - February 19 2010 Issue



  1. Review: Neuraminidase inhibitors relieve influenza symptoms and reduce laboratory-confirmed influenza in healthy adults.
    • Ann Intern Med. 2010;152:JC211.
  2. Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, et al.
    • Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    • Biochem Biophys Res Commun. 2010.
    • Abstract available
  3. Shi P, Keskinocak P, Swann JL, Lee BY, et al.
    • Modelling seasonality and viral mutation to predict the course of an influenza pandemic.
    • Epidemiol Infect. 2010.
    • Abstract available
  4. Singh K, Vasoo S, Stevens J, Schreckenberger P, et al.
    • Pitfalls in the Diagnosis of Pandemic (Novel) A/H1N1 2009 Influenza.
    • J Clin Microbiol. 2010.
    • Abstract available
  5. Arya SC, Agarwal N.
    • Re: Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: An Experience with Better Test Performance in Resource Limited Setting.
    • J Infect. 2010.
  6. Mao H, Tu W, Liu Y, Qin G, et al.
    • Inhibition of human natural killer cell activity by influenza virion and hemagglutinin.
    • J Virol. 2010.
    • Abstract available
  7. Furuya Y, Chan J, Regner M, Lobigs M, et al.
    • Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.
    • J Virol. 2010.
    • Abstract available
  8. Wang W, Xie H, Ye Z, Vassell R, et al.
    • Characterization of Lentiviral Pseudotypes with Influenza H5N1 Hemagglutinin and Their Performance in Neutralization Assays.
    • J Virol Methods. 2010.
    • Abstract available
  9. Laurance J.
    • The swine flu backlash.
    • Lancet. 2010;375:367.
  10. Zhu W, Higgs BW, Morehouse C, Streicher K, et al.
    • A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.
    • Vaccine. 2010.
    • Abstract available
  11. Richard SA, Viboud C, Miller MA.
    • Evaluation of Southern Hemisphere influenza vaccine recommendations.
    • Vaccine. 2010.
    • Abstract available
  12. Savulescu C, Valenciano M, de Mateo S, Larrauri A, et al.
    • Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups, 2008-2009 season, Spain.
    • Vaccine. 2010.
    • Abstract available
  13. Hawkes M, Richardson SE, Ipp M, Schuh S, et al.
    • Sensitivity of Rapid Influenza Diagnostic Testing for Swine-Origin 2009 A (H1N1) Influenza Virus in Children.
    • Pediatrics. 2010.
    • Abstract available
  14. Cruz AT, Demmler-Harrison GJ, Caviness AC, Buffone GJ, et al.
    • Performance of a Rapid Influenza Test in Children During the H1N1 2009 Influenza A Outbreak.
    • Pediatrics. 2010.
    • Abstract available
-
------
 
Research Articles Abstracts - February 26, 2010 Issue

Research Articles Abstracts - February 26, 2010 Issue

Research Articles Abstracts - February 26, 2010 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - February 26, 2010 Issue


  1. Maurer J, Harris KM.
    • The Scope and Targeting of Influenza Vaccination Reminders Among US Adults: Evidence From a Nationally Representative Survey.
    • Arch Intern Med. 2010;170:390-2.
  2. Karlsson EA, Sheridan PA, Beck MA.
    • Diet-Induced Obesity Impairs the T Cell Memory Response to Influenza Virus Infection.
    • J Immunol. 2010.
    • Abstract available
  3. Hedlund M, Aschenbrenner LM, Jensen K, Larson JL, et al.
    • Sialidase-Based Anti-Influenza Virus Therapy Protects against Secondary Pneumococcal Infection.
    • J Infect Dis. 2010.
    • Abstract available
  4. Schwartz JA, Buonocore L, Suguitan AL Jr, Silaghi A, et al.
    • Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-term Sterilizing Immunity Against Heterologous Challenge.
    • J Virol. 2010.
    • Abstract available
  5. Bussey KA, Bousse TL, Desmet EA, Kim B, et al.
    • PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells.
    • J Virol. 2010.
    • Abstract available
  6. Belser JA, Wadford DA, Pappas C, Gustin KM, et al.
    • Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in Mice.
    • J Virol. 2010.
    • Abstract available
  7. Solorzano A, Ye J, Perez DR.
    • Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.
    • J Virol. 2010.
    • Abstract available
  8. Hai R, Schmolke M, Varga ZT, Manicassamy B, et al.
    • PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models.
    • J Virol. 2010.
    • Abstract available
  9. Wang D, Harmon A, Jin J, Francis DH, et al.
    • The Lack of an Inherent Membrane Targeting Signal is Responsible for the Failure of the Matrix (M1) Protein of Influenza A Virus to Bud into Virus-Like-Particles.
    • J Virol. 2010.
    • Abstract available
  10. Vanderlinden E, Goktas F, Cesur Z, Froeyen M, et al.
    • Novel inhibitors of influenza virus fusion: structure activity relationship and interaction with the viral hemagglutinin.
    • J Virol. 2010.
    • Abstract available
  11. This year in medicine: 2009.
    • Lancet. 2009;374:2027.
  12. Outbreak of 2009 Pandemic Influenza A (H1N1) on a Peruvian Navy Ship --- June--July 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:162-5.
    • Abstract available
  13. Li C, Hatta M, Nidom CA, Muramoto Y, et al.
    • Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence.
    • Proc Natl Acad Sci U S A. 2010.
    • Abstract available
-
------
 
Research Articles Abstracts - March 5, 2010 Issue

Research Articles Abstracts - March 5, 2010 Issue

Research Articles Abstracts - March 5, 2010 Issue

[Source Abstracts: LINK. EDITED.]

Research Articles Abstracts - March 5, 2010 Issue



  1. Gong T, Jiang Y, Wang Y, Yang D, et al.
    • Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry.
    • Arch Virol. 2010.
    • Abstract available
  2. Sui Z, Chen Q, Wu R, Zhang H, et al.
    • Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    • Arch Virol. 2010.
    • Abstract available
  3. Rathe JA, Liu X, Tallon LJ, Gern JE, et al.
    • Full-genome sequence and analysis of a novel human rhinovirus strain within a divergent HRV-A clade.
    • Arch Virol. 2010;155:83-7.
    • Abstract available
  4. Stone J.
    • English mortality from A/H1N1. Discrepancies in published data.
    • BMJ. 2010;340:c613.
  5. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, et al.
    • English mortality from A/H1N1. Comparisons with recent flu mortality.
    • BMJ. 2010;340:c612.
  6. Watson R.
    • Council of Europe launches investigation into H1N1 pandemic.
    • BMJ. 2010;340:c641.
  7. McDowall MA.
    • Spanish flu through BMJ eyes. Prevention by toxic gases?
    • BMJ. 2010;340:c283.
  8. Kato T, Kawaguchi A, Nagata K, Hatanaka K, et al.
    • Development of tetraphenylethylene-based fluorescent oligosaccharide probes for detection of influenza virus.
    • Biochem Biophys Res Commun. 2010.
    • Abstract available
  9. Chapman TJ, Topham DJ.
    • Identification of a Unique Population of Tissue-Memory CD4+ T Cells in the Airways after Influenza Infection That Is Dependent on the Integrin VLA-1.
    • J Immunol. 2010.
    • Abstract available
  10. Bastien N, Antonishyn NA, Brandt K, Wong CE, et al.
    • Human Infection with a Triple-Reassortant Swine Influenza A(H1N1) Virus Containing the Hemagglutinin and Neuraminidase Genes of Seasonal Influenza Virus.
    • J Infect Dis. 2010.
    • Abstract available
  11. Whitley RJ.
    • Of ferrets and humans: influenza pathogenesis.
    • J Infect Dis. 2010;201:976-7.
  12. van den Brand JM, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, et al.
    • Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus.
    • J Infect Dis. 2010;201:993-9.
    • Abstract available
  13. France AM, Jackson M, Schrag S, Lynch M, et al.
    • Household Transmission of 2009 Influenza A (H1N1) Virus after a School-Based Outbreak in New York City, April-May 2009.
    • J Infect Dis. 2010;201:984-92.
    • Abstract available
  14. Sun K, Torres L, Metzger DW.
    • A Detrimental Effect of IL-10 on Protective Pulmonary Humoral Immunity during Primary Influenza A Virus Infection.
    • J Virol. 2010.
    • Abstract available
  15. Xu Q, Wang W, Cheng X, Zengel J, et al.
    • Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity and immunogenicity in ferrets.
    • J Virol. 2010.
    • Abstract available
  16. de Wit E, Munster VJ, van Riel D, Beyer WE, et al.
    • Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host.
    • J Virol. 2010;84:1597-606.
    • Abstract available
  17. Meyerhoff A, Lietman P.
    • Losing the opportunity to study influenza drugs.
    • JAMA. 2010;303:878-9.
  18. ...
    • InFACT: a global critical care research response to H1N1.
    • Lancet. 2010;375:11-3.
  19. Wallinga J, van Boven M, Lipsitch M.
    • Optimizing infectious disease interventions during an emerging epidemic.
    • Proc Natl Acad Sci U S A. 2010;107:923-8.
    • Abstract available
  20. Li Z, Doan Q, Dobson S.
    • Determinants of influenza immunization uptake in Canadian youths.
    • Vaccine. 2010.
    • Abstract available
  21. Caillet C, Piras F, Bernard MC, de Montfort A, et al.
    • AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    • Vaccine. 2010.
    • Abstract available
  22. Bettinger JA, Sauve LJ, Scheifele DW, Moore D, et al.
    • Pandemic influenza in Canadian children: A summary of hospitalized pediatric cases.
    • Vaccine. 2010.
    • Abstract available
  23. Machado AV, Caetano BC, Barbosa RP, Salgado AP, et al.
    • Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.
    • Vaccine. 2010.
    • Abstract available
  24. Hwang SD, Shin JS, Ku KB, Kim HS, et al.
    • Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination.
    • Vaccine. 2010.
    • Abstract available
  25. Hartgroves LC, Koudstaal W, McLeod C, Moncorge O, et al.
    • Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.
    • Vaccine. 2010.
    • Abstract available
  26. Desmet EA, Hollenbaugh JA, Sime PJ, Wright TW, et al.
    • Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells.
    • Virology. 2010.
    • Abstract available
  27. Bussmann BM, Reiche S, Bieniek B, Krznaric I, et al.
    • Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.
    • Virology. 2009.
    • Abstract available
  28. Mizuta K, Hirata A, Suto A, Aoki Y, et al.
    • Phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from children with acute respiratory infections in Yamagata, Japan.
    • Virus Res. 2010;147:265-74.
    • Abstract available
  29. Laham FR, Trott AA, Bennett BL, Kozinetz CA, et al.
    • LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity.
    • Pediatrics. 2010;125:e225-33.
    • Abstract available
  30. Okomo-Adhiambo M, Demmler-Harrison GJ, Deyde VM, Sheu TG, et al.
    • Detection E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir-Resistance.
    • Antimicrob Agents Chemother. 2010.
    • Abstract available
  31. Karpenko I, Deev S, Kiselev O, Charushin V, et al.
    • A NOVEL AZOLO-1,2,4-TRIAZINE-DERIVED INHIBITOR OF INFLUENZA A AND B VIRUS REPLICATION: ANTIVIRAL PROPERTIES, METABOLISM, AND PHARMACOKINETICS.
    • Antimicrob Agents Chemother. 2010.
    • Abstract available
-
------
 
Research Articles Abstracts - March 13 2010 Issue

Research Articles Abstracts - March 13 2010 Issue

[Source: US National Library of Medicine, LINK. EDITED.]

Research Articles Abstracts - March 13 2010 Issue



  1. Hata M, Tanaka S, Yasui Y, Fujiwara N, et al.
    • A rapid genotypic assay for the detection of oseltamivir-resistant influenza A (H1N1) viruses.
    • J Clin Microbiol. 2010.
    • PubMed
    • Abstract available
  2. Perez-Ruiz M, Navarro-Mari JM, Bautista-Marin MF, Pedrosa-Corral I, et al.
    • Development and preliminary evaluation of a rapid oligochromatographic assay for the specific detection of new human influenza A H1N1 virus.
    • J Clin Microbiol. 2010.
    • PubMed
    • Abstract available
  3. Hindiyeh M, Ram D, Mandelboim M, Meningher T, et al.
    • Rapid Detection of Influenza A Pandemic (H1N1) 2009 Virus Neuraminidase Resistance Mutation H275Y by Real-Time RT-PCR.
    • J Clin Microbiol. 2010.
    • PubMed
    • Abstract available
  4. McGill J, Van Rooijen N, Legge KL.
    • IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection.
    • J Exp Med. 2010.
    • PubMed
    • Abstract available
  5. Langlois RA, Legge KL.
    • Plasmacytoid Dendritic Cells Enhance Mortality during Lethal Influenza Infections by Eliminating Virus-Specific CD8 T Cells.
    • J Immunol. 2010.
    • PubMed
    • Abstract available
  6. Shu Y, Li CK, Li Z, Gao R, et al.
    • Avian Influenza A(H5N1) Viruses Can Directly Infect and Replicate in Human Gut Tissues.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  7. DeLeo FR, Musser JM.
    • Axis of coinfection evil.
    • J Infect Dis. 2010;201:488-90.
    • PubMed
  8. Versteeg GA, Hale BG, van Boheemen S, Wolff T, et al.
    • Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  9. Rossman JS, Jing X, Leser GP, Balannik V, et al.
    • Influenza Virus M2 Ion Channel Protein is Necessary for Filamentous Virion Formation.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  10. Hoelzer K, Murcia PR, Baillie GJ, Wood JL, et al.
    • Intra-host evolutionary dynamics of canine influenza virus in naive and partially immune dogs.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  11. Okumura Y, Takahashi E, Yano M, Ohuchi M, et al.
    • Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  12. Takekawa JY, Iverson SA, Schultz AK, Hill NJ, et al.
    • Field detection of avian influenza virus in wild birds: evaluation of a portable RRT-PCR system and freeze dried reagents.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
  13. Loeb M, Russell ML, Moss L, Fonseca K, et al.
    • Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial.
    • JAMA. 2010;303:943-50.
    • PubMed
    • Abstract available
  14. Laudi S, Busch T, Kaisers U.
    • Extracorporeal membrane oxygenation for ARDS due to 2009 influenza A(H1N1).
    • JAMA. 2010;303:941.
    • PubMed
  15. Freebairn R, McHugh G, Hickling K.
    • Extracorporeal membrane oxygenation for ARDS due to 2009 influenza A(H1N1).
    • JAMA. 2010;303:941-2.
    • PubMed
  16. Spronk PE, Schultz MJ.
    • Mechanical ventilation in critically ill patients with 2009 influenza A(H1N1).
    • JAMA. 2010;303:939-40.
    • PubMed
  17. Finkelstein Y, Schechter T, Freedman SB.
    • Surgical masks vs N95 respirators for preventing influenza.
    • JAMA. 2010;303:938.
    • PubMed
  18. Palen TE, Felix KG.
    • Surgical masks vs N95 respirators for preventing influenza.
    • JAMA. 2010;303:937.
    • PubMed
  19. Bitar R.
    • Surgical masks vs N95 respirators for preventing influenza.
    • JAMA. 2010;303:937.
    • PubMed
  20. Clynes N.
    • Surgical masks vs N95 respirators for preventing influenza.
    • JAMA. 2010;303:937-8.
    • PubMed
  21. Kahr V, Barrett NA, Shankar-Hari M, Slack H, et al.
    • A life-threatening sore throat masquerading as swine flu.
    • Lancet. 2010;375:524.
    • PubMed
  22. Numata M, Chu HW, Dakhama A, Voelker DR, et al.
    • Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.
    • Proc Natl Acad Sci U S A. 2010;107:320-5.
    • PubMed
    • Abstract available
  23. Althouse BM, Bergstrom TC, Bergstrom CT.
    • Evolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseases.
    • Proc Natl Acad Sci U S A. 2010;107 Suppl 1:1696-701.
    • PubMed
    • Abstract available
  24. Tenbusch M, Grunwald T, Niezold T, Bonsmann MS, et al.
    • Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  25. Gijzen K, Liu WM, Visontai I, Oftung F, et al.
    • Standardization and validation of assays determining cellular immune responses against influenza.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  26. Leung BW, Chen H, Brownlee GG.
    • Correlation between polymerase activity and pathogenicity in two duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity.
    • Virology. 2010.
    • PubMed -
    • Abstract available
-
------
 
Research Articles Abstracts - March 19 2010 Issue

Research Articles Abstracts - March 19 2010 Issue

Research Articles Abstracts - March 19 2010 Issue

[Source: US National Library of Medicine (LINK). Edited.]

Research Articles Abstracts - March 19 2010 Issue


  1. Surgical masks were noninferior to N95 respirators for preventing influenza in health care providers.Ann Intern Med. 2010;152:JC32.
  2. Review: Extended-duration chemoprophylaxis with neuraminidase inhibitors prevents symptomatic influenza.
    • Ann Intern Med. 2010;152:JC33.
  3. Nagy A, Vostinakova V, Pirchanova Z, Cernikova L, et al.
    • Development and evaluation of a one-step real-time RT-PCR assay for universal detection of influenza A viruses from avian and mammal species.
    • Arch Virol. 2010.
    • PubMed - Abstract available
  4. Hagiwara K, Kondoh Y, Ueda A, Yamada K, et al.
    • Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
    • Biochem Biophys Res Commun. 2010.
    • PubMed - Abstract available
  5. Horby P, Sudoyo H, Viprakasit V, Fox A, et al.
    • What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1?
    • Epidemiol Infect. 2010.
    • PubMed - Abstract available
  6. Dutra IF, Bettencourt BF, Fialho RN, Couto AR, et al.
    • A novel Fast RT-PCR assay for Molecular Detection of Human Influenza A (H1N1).
    • J Clin Microbiol. 2010.
    • PubMed - Abstract available
  7. Hale BG, Steel J, Manicassamy B, Medina RA, et al.
    • Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus.
    • J Gen Virol. 2010.
    • PubMed - Abstract available
  8. Yu CF, Peng WM, Oldenburg J, Hoch J, et al.
    • Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation.
    • J Immunol. 2010;184:1159-67.
    • PubMed - Abstract available
  9. Eisenhut M.
    • Influenza Virus Amplifies Interaction of Polymeric Immunoglobulin Receptor with Pneumococcal Surface Protein A, which Mediates Invasion by Pneumococcus.
    • J Infect Dis. 2010;201:1272-3.
    • PubMed
  10. Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, et al.
    • Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors.
    • J Virol. 2010.
    • PubMed - Abstract available
  11. Ghedin E, Wentworth D, Halpin RA, Lin X, et al.
    • Unseasonal Transmission of H3N2 Influenza A Virus During the Swine-Origin H1N1 Pandemic.
    • J Virol. 2010.
    • PubMed - Abstract available
  12. Stark JM, Barmada MM, Winterberg AV, Majumber N, et al.
    • Genomewide association analysis of respiratory syncytial virus infection in mice.
    • J Virol. 2010;84:2257-69.
    • PubMed - Abstract available
  13. Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, et al.
    • A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.
    • J Virol. 2010;84:2374-83.
    • PubMed - Abstract available
  14. Respiratory syncytial virus activity - United States, July 2008-December 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:230-3.
    • PubMed - Abstract available
  15. Ramey AM, Pearce JM, Flint PL, Ip HS, et al.
    • Intercontinental reassortment and genomic variation of low pathogenic avian influenza viruses isolated from northern pintails (Anas acuta) in Alaska: Examining the evidence through space and time.
    • Virology. 2010.
    • PubMed - Abstract available
  16. Retraction. Retraction notice to "The NSI gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses" [Virus Res. 103 (2004) 107-113].
    • Virus Res. 2010;149:133.
  17. Baek YH, Pascua PN, Song MS, Park KJ, et al.
    • Surveillance and characterization of low pathogenic H5 avian influenza viruses isolated from wild migratory birds in Korea.
    • Virus Res. 2010.
    • PubMed
    • Abstract available

-
------
 
Research Articles Abstracts - March 27 2010 Issue

Research Articles Abstracts - March 27 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - March 27 2010 Issue


  1. Stone AA, Krueger AB, Steptoe A, Harter JK, et al.
    • The socioeconomic gradient in daily colds and influenza, headaches, and pain.
    • Arch Intern Med. 2010;170:570-2.
    • PubMed
  2. Jandaghi NZ, Azad TM, Naseri M, Yavarian J, et al.
    • Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses.
    • Arch Virol. 2010.
    • PubMed
    • Abstract available
  3. Liu X, Wu C, Chen AY.
    • Codon usage bias and recombination events for neuraminidase and hemagglutinin genes in Chinese isolates of influenza A virus subtype H9N2.
    • Arch Virol. 2010.
    • PubMed
    • Abstract available
  4. ...
    • Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study.
    • BMJ. 2010;340:c1279.
    • PubMed
    • Abstract available
  5. Lapinsky SE.
    • Critical illness as a result of influenza A/H1N1 infection in pregnancy.
    • BMJ. 2010;340:c1235.
    • PubMed
  6. Gran JM, Iversen B, Hungnes O, Aalen OO, et al.
    • Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004.
    • Epidemiol Infect. 2010.
    • PubMed
    • Abstract available
  7. Greer AL, Tuite A, Fisman DN.
    • Age, influenza pandemics and disease dynamics.
    • Epidemiol Infect. 2010.
    • PubMed
    • Abstract available
  8. Bodewes R, Kreijtz JH, Hillaire M, Geelhoed-Mieras MM, et al.
    • Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza A/H5N1 and immunodominance of virus specific CD8+ T cell responses in mice.
    • J Gen Virol. 2010.
    • PubMed
    • Abstract available
  9. Ho A, Fox R, Seaton RA, MacConnachie A, et al.
    • Hospitalised adult patients with Suspected 2009 H1N1 Infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses.
    • J Infect. 2010;60:83-5.
    • PubMed
  10. Bos ME, Te Beest DE, van Boven M, van Beest Holle MR, et al.
    • High Probability of Avian Influenza Virus (H7N7) Transmission from Poultry to Humans Active in Disease Control on Infected Farms.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  11. Nakamura R, Maeda N, Shibata K, Yamada H, et al.
    • Interleukin-15 is critical in the pathogenesis of influenza A virus-induced acute lung injury.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  12. Fink M, Revilla Fernandez S, Schobesberger H, Koefer J, et al.
    • Geographical spread of highly pathogenic Avian Influenza Virus (HPAIV) H5N1 during the 2006 outbreak in Austria.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  13. Yang Y, Gonzalez R, Huang F, Wang W, et al.
    • Simultaneous typing and HA/NA subtyping of influenza A and B viruses including the pandemic influenza A/H1N1 2009 by multiplex real-time RT-PCR.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
  14. Krammer F, Schinko T, Messner P, Palmberger D, et al.
    • Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
  15. Kuehn BM.
    • CDC advisory committee recommends nearly universal influenza vaccination.
    • JAMA. 2010;303:1136.
    • PubMed
  16. Janjua NZ, Skowronski DM, Hottes TS, De Serres G, et al.
    • Seasonal vaccine effectiveness against pandemic A/H1N1.
    • Lancet. 2010;375:801-2.
    • PubMed
  17. Barber MR, Aldridge JR Jr, Webster RG, Magor KE, et al.
    • Association of RIG-I with innate immunity of ducks to influenza.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
  18. Hussain AI, Cordeiro M, Sevilla E, Liu J, et al.
    • Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cel
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  19. Rizzo C, Rota MC, Bella A, Alfonsi V, et al.
    • Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  20. Halliley JL, Kyu S, Kobie JJ, Walsh EE, et al.
    • Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  21. Rowe T, Leon AJ, Crevar CJ, Carter DM, et al.
    • Modeling host responses in ferrets during A/California/07/2009 influenza infection.
    • Virology. 2010.
    • PubMed
    • Abstract available
  22. Takizawa N, Kumakura M, Takeuchi K, Kobayashi N, et al.
    • Sorting of influenza A virus RNA genome segments after nuclear export.
    • Virology. 2010.
    • PubMed
    • Abstract available
  23. Takehara K, Yamazaki K, Miyazaki M, Yamada Y, et al.
    • Inactivation of Avian Influenza Virus H1N1 by Photocatalyst under Visible Light Irradiation.
    • Virus Res. 2010.
    • PubMed
    • Abstract available
-
------
 
Research Articles Abstracts - April 2nd, 2010 Issue

Research Articles Abstracts - April 2nd, 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - April 2nd, 2010 Issue



  1. Choi YJ, Kim HJ, Park JS, Oh MH, et al.
    • Evaluation of New Rapid Antigen Test for the Detection of Pandemic Influenza A/H1N1 2009 Virus.
    • J Clin Microbiol. 2010.
    • PubMed
    • Abstract available
  2. Seitz C, Frensing T, Hoper D, Kochs G, et al.
    • High yields of Influenza A virus in MDCK cells are promoted by an insufficient IFN-induced antiviral state.
    • J Gen Virol. 2010.
    • PubMed
    • Abstract available
  3. Memoli MJ, Hrabal RJ, Hassantoufighi A, Jagger BW, et al.
    • Rapid Selection of a Transmissible Multidrug-Resistant Influenza A/H3N2 Virus in an Immunocompromised Host.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  4. Bruce EA, Digard P, Stuart AD.
    • The Rab11 pathway is required for influenza A viral budding and filament formation.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  5. Forrest HL, Kim JK, Webster RG.
    • Virus shedding and potential for interspecies waterborne transmission of highly pathogenic H5N1 influenza virus in sparrows and chickens.
    • J Virol. 2010;84:3718-20.
    • PubMed
    • Abstract available
  6. ...
    • 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:321-6.
    • PubMed
    • Abstract available
  7. Le Ru A, Jacob D, Transfiguracion J, Ansorge S, et al.
    • Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  8. Poland GA, Morse D.
    • Improving the public health: the U.S. recommendation for universal influenza immunization.
    • Vaccine. 2010;28:2799-800.
    • PubMed
  9. Huang Y, Hu B, Wen X, Cao S, et al.
    • Diversified reassortant H9N2 avian influenza viruses in chicken flocks in northern and eastern China.
    • Virus Res. 2010.
    • PubMed
    • Abstract available
  10. Yang JR, Lin CH, Chen CJ, Liu JL, et al.
    • A new antigenic variant of human influenza A (H3N2) virus isolated from airport and community surveillance in Taiwan in early 2009.
    • Virus Res. 2010.
    • PubMed
    • Abstract available
  11. Sleeman K, Mishin VP, Deyde VM, Furuta Y, et al.
    • In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    • Antimicrob Agents Chemother. 2010.
    • PubMed
    • Abstract available
-
------
 
Research Articles Abstracts - April 9 2010 Issue

Research Articles Abstracts - April 9 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - April 9 2010 Issue


  1. ...
    • Case studies of lower respiratory tract infections: community-acquired pneumonia.
    • Am J Med. 2010;123.
    • PubMed
    • Abstract available
  2. Lai AR, Keet K, Yong CM, Diaz JV, et al.
    • Severe H1N1-Associated acute respiratory distress syndrome: A case series.
    • Am J Med. 2010;123:282-285.
    • PubMed
    • Abstract available
  3. Tolnay AE, Baskin CR, Tumpey TM, Sabourin PJ, et al.
    • Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus.
    • Arch Virol. 2010.
    • PubMed
    • Abstract available
  4. Matsuda M, Suizu F, Hirata N, Miyazaki T, et al.
    • Characterization of the interaction of Influenza virus NS1 with Akt.
    • Biochem Biophys Res Commun. 2010.
    • PubMed
    • Abstract available
  5. Wang X, Shen Y, Qiu Y, Shi Z, et al.
    • The non-structural (NS1) protein of influenza A virus associates with p53 and inhibits p53-mediated transcriptional activity and apoptosis.
    • Biochem Biophys Res Commun. 2010.
    • PubMed
    • Abstract available
  6. Zhang J, Zhang Z, Fan X, Liu Y, et al.
    • 2009 Pandemic H1N1 Influenza Virus Replicates in Human Lung Tissues.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  7. Doshi P.
    • Pandemic influenza: severity must be taken into account.
    • J Infect Dis. 2010;201:1444-5.
    • PubMed
  8. Chen H, Wen X, To KK, Wang P, et al.
    • Quasispecies of the D225G Substitution in the Hemagglutinin of Pandemic Influenza A(H1N1) 2009 Virus from Patients with Severe Disease in Hong Kong, China.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  9. Oshansky CM, Barber JP, Crabtree J, Tripp RA, et al.
    • Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.
    • J Infect Dis. 2010;201:1201-7.
    • PubMed
    • Abstract available
  10. Harker JA, Godlee A, Wahlsten JL, Lee DC, et al.
    • Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
    • J Virol. 2010;84:4073-82.
    • PubMed
    • Abstract available
  11. Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, et al.
    • Human rhinovirus 14 enters rhabdomyosarcoma cells expressing icam-1 by a clathrin-, caveolin-, and flotillin-independent pathway.
    • J Virol. 2010;84:3984-92.
    • PubMed
    • Abstract available
  12. Lednicky JA, Villanueva JM, Burke SA, Shively R, et al.
    • Validation of a Method for Preparing Influenza H5N1 Simulated Samples.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
  13. Hymas WC, Mills A, Ferguson S, Langer J, et al.
    • Development of a multiplex real-time RT-PCR assay for detection of Influenza A, Influenza B, RSV and typing of the 2009-H1N1 influenza virus.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
  14. ...
    • Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010.
    • MMWR Morb Mortal Wkly Rep. 2010;59:363-8.
    • PubMed
    • Abstract available
  15. ...
    • Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel - United States, August 2009-January 2010.
    • MMWR Morb Mortal Wkly Rep. 2010;59:357-62.
    • PubMed
    • Abstract available
  16. dos Santos MC, Alecrim MG.
    • Images in clinical medicine. Varicella pneumonia in an adult.
    • N Engl J Med. 2010;362:1227.
    • PubMed
  17. Molloy GJ.
    • Increasing influenza vaccination rates: Where is the behaviour change theory?
    • Vaccine. 2010.
    • PubMed
  18. Chung EY, Huang L, Schneider L.
    • Safety of Influenza Vaccine Administration in Egg-Allergic Patients.
    • Pediatrics. 2010.
    • PubMed
    • Abstract available
  19. Sugaya N, Ohashi Y.
    • Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection.
    • Antimicrob Agents Chemother. 2010.
    • PubMed
    • Abstract available
-
------
 
Research Articles Abstracts - April 17, 2010

Research Articles Abstracts - April 17, 2010

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - April 17, 2010



  1. Wang B, Dwyer DE, Blyth CC, Soedjono M, et al.
    • Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    • Antiviral Res. 2010.
    • PubMed
    • Abstract available
  2. Iorio A, Basileo M, Marcucci M, Guercini F, et al.
    • Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study.
    • Arch Intern Med. 2010;170:609-16.
    • PubMed
    • Abstract available
  3. Monteerarat Y, Suptawiwat O, Boonarkart C, Uiprasertkul M, et al.
    • Inhibition of H5N1 highly pathogenic influenza virus by suppressing a specific sialyltransferase.
    • Arch Virol. 2010.
    • PubMed
    • Abstract available
  4. Marjuki H, Scholtissek C, Franks J, Negovetich NJ, et al.
    • Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks.
    • Arch Virol. 2010.
    • PubMed
    • Abstract available
  5. Pitaksajjakul P, Lekcharoensuk P, Uparagarin N, Iii CF, et al.
    • Fab MAbs Specific to HA of Influenza Virus with H5N1 Neutralizing Activity Selected from Immunized Chicken Phage Library.
    • Biochem Biophys Res Commun. 2010.
    • PubMed
    • Abstract available
  6. Puzelli S, Buonaguro FM, Facchini M, Palmieri A, et al.
    • Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus.
    • J Clin Microbiol. 2010.
    • PubMed
    • Abstract available
  7. Kang S, Yang IS, Lee JY, Park Y, et al.
    • Epidemiologic Study of Human Influenza Infection in Korea from 1999 to 2007: Origin and Evolution of A/Fujian/411/2002-like strains.
    • J Clin Microbiol. 2010.
    • PubMed
    • Abstract available
  8. Kim HR, Park CK, Oem JK, Bae YC, et al.
    • Characterization of H5N2 influenza viruses isolated in South Korea and their influence on the emergence of a novel H9N2 influenza virus.
    • J Gen Virol. 2010.
    • PubMed
    • Abstract available
  9. Neumann G, Green MA, Macken CA.
    • Evolution of highly pathogenic avian H5N1 influenza viruses and the emergence of dominant variants.
    • J Gen Virol. 2010.
    • PubMed
    • Abstract available
  10. Tang Y, Zhong G, Zhu L, Liu X, et al.
    • Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein.
    • J Immunol. 2010.
    • PubMed
    • Abstract available
  11. Lau LL, Cowling BJ, Fang VJ, Chan KH, et al.
    • Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  12. Chutinimitkul S, van Riel D, Munster VJ, van den Brand JM, et al.
    • In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  13. Ma XJ, Shu YL, Nie K, Wang MQ, et al.
    • Visual Detection of Pandemic Influenza A H1N1 Virus 2009 by Reverse Transcription Loop-Mediated Isothermal Amplification with Hydroxynaphthol Blue Dye.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
  14. Chen MI, Lee VJ, Lim WY, Barr IG, et al.
    • 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.
    • JAMA. 2010;303:1383-91.
    • PubMed
    • Abstract available
  15. Zhang T, Wang CY, Zhang W, Gao YW, et al.
    • Generation and characterization of a fusion protein of single-chain fragment variable antibody against hemagglutinin antigen of avian influenza virus and truncated protamine.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  16. Fusco D, Liu X, Salvatore M, Savage C, et al.
    • Echinacea purpurea aerial extract alters course of influenza infection in mice.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  17. Xue W, Ellis J, Mattick D, Smith L, et al.
    • Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young ca
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  18. Chlibek R, Anca I, Andre F, Bakir M, et al.
    • Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  19. Linlin B, Lili X, Lingjun Z, Wei D, et al.
    • Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals.
    • Virus Res. 2010.
    • PubMed
    • Abstract available
-
------
 
Re: Research Articles Abstracts - April 17, 2010

Re: Research Articles Abstracts - April 17, 2010

what's the best way to keep updated here ?

currently I'm doing :
http://www.hubmed.org
then "influenza"
then "hide extracts" or "show extracts" depending on how much time I want to spend..

I noticed that sometimes hubmed is not as actual a pubmed


or:
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed
influenza
Results: 1 to 20 of 55049
Display Settings
*summary/text *100 *recently added


best would be (IMO) just the headlines , no authors, no journal name,
one line per clickable headline
and then store the whole list for keyword-search

the same could be done with all the abstracts included

is it being done ? is it allowed (copyright) ?
 
Re: Research Articles Abstracts - April 17, 2010

Re: Research Articles Abstracts - April 17, 2010

HubMed seems a nice tools.

My lists are based upon a weekly newsletter dispatched by a review.

However, since this service is sponsored by a drug company I cannot disclose the name in adherence of FluTrackers.com policy.

Other contributors can add their suggests for a better coverage of these topics.;)
 
Re: Research Articles Abstracts - April 17, 2010

Re: Research Articles Abstracts - April 17, 2010

last 200, no links yet

Code:
Isolation and molecular characterization of a H5N1 virus isolated from a Junglecrow (Corvus macrohynchos) in India. [164]
Experimental modeling of viral diseases of the locomotor system. [165]
[A histopathological study on Influenza A H1N1 infection in humans.] [166]
Update: influenza activity - United States, August 30, 2009-March 27, 2010, andcomposition of the 2010-11 influenza vaccine. [167]
Zinc Intake and Resistance to H1N1 Influenza. [168]
[Characteristics of hepatitis and influenza antivirals: update 2009.] [169]
Risk factors for detection of bronchial casts, most frequently seen in endemicH9N2 avian influenza infection, in poultry flocks in Iran. [170]
A randomized controlled trial of low-dose recombinant human interferonsalpha-2b nasal spray to prevent acute viral respiratory infections in militaryrecruits. [171]
Long-term immunogenicity of influenza vaccine among the elderly: Risk factorsfor poor immune response and persistence. [172]
The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virusamongst hospitalised immunocompromised patients in Scotland, November-December,2009. [173]
Association of D222G substitution in haemagglutinin of 2009 pandemic influenzaA (H1N1) with severe disease. [174]
Changes in receiving preventive care services among US adults with diabetes,1997-2007. [175]
Identification of Hits as Matrix-2 Protein Inhibitors through the FocusedScreening of a Small Primary Amine Library. [176]
Cardiac tamponade and heart failure due to myopericarditis as a presentation ofinfection with the pandemic H1N1 2009 influenza A virus. [177]
Epidemiologic Study of Human Influenza Infection in Korea from 1999 to 2007:Origin and Evolution of A/Fujian/411/2002-like strains. [179]
Characterization of H5N2 influenza viruses isolated in South Korea and theirinfluence on the emergence of a novel H9N2 influenza virus. [181]
Evolution of highly pathogenic avian H5N1 influenza viruses and the emergenceof dominant variants. [183]
In vitro assessment of attachment pattern and replication efficiency of H5N1influenza A viruses with altered receptor specificity. [185]
Myocarditis associated with 2009 influenza A (H1N1) virus in children. [187]
Clinical features of H1N1 2009 infection in critically ill immunocompromisedpatients. [189]
The essentiality of alpha-2-macroglobulin in human salivary innate immunityagainst new H1N1 swine origin influenza A virus. [191]
An outbreak of H7N6 low pathogenic avian influenza in quails in Japan. [193]
Isolation of influenza A viruses from pigs in Ibadan, Nigeria. [195]
Standardisation of a new model of H9N2/Escherichia coli challenge in broilersin the Lebanon. [197]
Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virusrepresent a risk factor, an acute trigger, or both? [198]
Susceptibility of two species of wild terrestrial birds to infection with ahighly pathogenic avian influenza virus of H5N1 subtype. [200]
Evaluation of different serological tests for the detection of antibodiesagainst highly pathogenic avian influenza in experimentally infected ostriches(Struthio camelus). [202]
Sequence and phylogenetic analysis of the haemagglutinin genes of H9N2 avianinfluenza viruses isolated from commercial chickens in Iran. [204]
CD28 and IL-4: two heavyweights controlling the balance between immunity andinflammation. [206]
Pandemic influenza: antiviral preparedness and health care workers. [208]
Which health care workers were most affected during the spring 2009 H1N1pandemic? [210]
Heterosubtypic neutralizing antibodies are produced by individuals immunizedwith a seasonal influenza vaccine. [212]
2009 influenza A(H1N1) seroconversion rates and risk factors among distinctadult cohorts in Singapore. [214]
A Computational Analysis of the Antigenic Properties of Haemagglutinin inInfluenza A H3N2. [216]
Reporting bias in medical research - a narrative review. [218]
[Characterization of human coronavirus 229E infection among patients withrespiratory symptom in Beijing, Oct-Dec, 2007] [220]
Faceoff: Cuba vs. H1N1 influenza. [222]
Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Dryingand Storage. [224]
Genetic variation of Italian avian paramyxoviruses serotype 9. [226]
Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-inducedpro-inflammatory cytokine and chemokine expression in human macrophages. [228]
Dynamics and control of diseases in networks with community structure. [230]
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1illness during Spring-Summer 2009: four observational studies from Canada.[233]
Does seasonal influenza vaccination increase the risk of illness with the 2009A/H1N1 pandemic virus? [236]
Economic appraisal of Ontario's Universal Influenza Immunization Program: acost-utility analysis. [239]
Spatial and temporal association of outbreaks of H5N1 influenza virus infectionin wild birds with the 0 degrees C isotherm. [242]
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled,randomized, double-blind crossover study. [245]
Utility of Influenza Vaccination for Oncology Patients. [247]
Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1Protein. [249]
Detection of the rapid emergence of the H275Y mutation associated withoseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.[251]
Computational study of drug binding to the membrane-bound tetrameric M2 peptidebundle from influenza A virus. [253]
Perception of epidemic's related anxiety in the General French Population: across-sectional study in the Rhone-Alpes region. [255]
Metabolic engineering for the production of shikimic acid in an evolvedEscherichia coli strain lacking the phosphoenolpyruvate: carbohydratephosphotransferase system. [257]
FLU, an amino acid substitution model for influenza proteins. [259]
Diagnostic accuracy of bedside antigen tests to correctly diagnose newInfluenza A/H1N1v Infection. [261]
[Influence of novel influenza pandemic in 2009 on mental state of workers atlocal public hospital: an investigation using questionnaire] [263]
Inhibition of H5N1 highly pathogenic influenza virus by suppressing a specificsialyltransferase. [265]
Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenzavirus affect pathogenicity in mallard ducks. [267]
Searching PubMed during a pandemic. [269]
Lymphocyte to monocyte ratio as a screening tool for influenza. [272]
A cross-sectional survey of influenza A infection and management practices insmall rural backyard poultry flocks in New Zealand. [275]
A cross-sectional survey of biosecurity practices on Thoroughbred stud farms inNew Zealand. [277]
Quantifying the contribution of leading causes of death to mortality declineamong older people in England, 1991-2005. [279]
Influenza virus activates inflammasomes via its intracellular M2 ion channel.[281]
Structures of influenza A proteins and insights into antiviral drug targets.[283]
[Mathematical Modeling of the Novel Influenza A (H1N1) Virus and Evaluation ofthe Epidemic Response Strategies in the Republic of Korea.] [285]
[The evaluation of policies on 2009 influenza pandemic in Korea.] [287]
[National Level Response to Pandemic (H1N1) 2009.] [289]
Pathology and Viral Antigen Distribution of Lethal Pneumonia in Domestic CatsDue to Pandemic (H1N1) 2009 Influenza A Virus. [291]
Variability in Pathobiology of South Korean H5N1 High-Pathogenicity AvianInfluenza Virus Infection for 5 Species of Migratory Waterfowl. [293]
Early host responses to avian influenza A virus are prolonged and enhanced attranscriptional level depending on maturation of the immune system. [295]
Generation and characterization of a fusion protein of single-chain fragmentvariable antibody against hemagglutinin antigen of avian influenza virus andtruncated protamine. [297]
Echinacea purpurea aerial extract alters course of influenza infection in mice.[299]
Optimal control for pandemic influenza: The role of limited antiviral treatmentand isolation. [301]
Detection of pandemic (H1N1) 2009 influenza virus by allele discrimination.[303]
Fab MAbs Specific to HA of Influenza Virus with H5N1 Neutralizing ActivitySelected from Immunized Chicken Phage Library. [305]
Where does amantadine bind to the influenza virus M2 proton channel? [307]
[A(H1N1) influenza surveillance in the french armed forces: Adapting thesurveillance systems to the pandemic setting.] [309]
Challenge and polymorphism analysis of the novel A (H1N1) influenza virus tonormal animals. [311]
Visual Detection of Pandemic Influenza A H1N1 Virus 2009 by ReverseTranscription Loop-Mediated Isothermal Amplification with Hydroxynaphthol BlueDye. [313]
Click reaction synthesis of carbohydrate derivatives from ristocetin aglyconwith antibacterial and antiviral activity. [315]
Central European Vaccination Advisory Group (CEVAG) guidance statement onrecommendations for 2009 pandemic influenza A(H1N1) vaccination. [317]
Comparison of Adjuvant Efficacy of Chitosan and Aluminum Hydroxide forIntraperitoneally Administered Inactivated Influenza H5N1 Vaccine. [319]
Mixed Infections of Pandemic H1N1 and Seasonal H3N2 Viruses in 1 Outbreak.[321]
Modelling the Transmission Dynamics and Control of the Novel 2009 SwineInfluenza (H1N1) Pandemic. [323]
Influenza A (H1N1) pneumonia in an immunossupressed patient after hearttransplantation. [325]
[Evaluation of a rapid antigenic method in the diagnosis of pandemic influenzaA (H1N1) virus in the pediatric population.] [327]
Improving emergency preparedness capability of rural public health personnel inChina. [329]
Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1,NIBRG-14) vaccine administered by intramuscular or subcutaneous injection.[331]
Viral Shedding and Clinical Illness in Naturally Acquired Influenza VirusInfections. [333]
Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy OlderAdults. [335]
Invasive Group A Streptococcal Infection Concurrent with 2009 H1N1 Influenza.[337]
Influenza vaccine coverage in age-related risk groups in Poland, 2004-2007.[339]
Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenzaand seasonal influenza during the "PROTECT" phase of the pandemic response.[341]
[Assessment of current disinfectants to create a reserve in case of avianinfluenza outbreak] [343]
Monitoring of all-cause mortality in Belgium (Be-MOMO): a new and automatedsystem for the early detection and quantification of the mortality impact ofpublic health events. [345]
Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)vvirus from recent human influenza viruses by real-time PCR. [347]
Features of the new pandemic influenza A/H1N1/2009 virus: virology,epidemiology, clinical and public health aspects. [350]
Occupational respiratory infections. [352]
Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-AdjuvantedPrepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years: A PhaseII, Randomized, Open, Controlled Study. [354]
Enhancement of Antiviral Activity of Collectin Trimers through Cross-Linkingand Mutagenesis of the Carbohydrate Recognition Domain. [356]
Verification of Poultry Carcass Composting Research through Application duringActual Avian Influenza Outbreaks. [358]
Frequent Detection of Pandemic (H1N1) 2009 Virus in Stools of HospitalizedPatients. [360]
Targeting pandemic influenza: a primer on influenza antivirals and drugresistance. [362]
Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans inviral evolution and vaccine design. [364]
H1N1: can a pandemic cycle be broken? [366]
Targeting Robo4-dependent slit signaling to survive the cytokine storm insepsis and influenza. [368]
Pig in a china shop: a personal perspective of how pandemic (H1N1) 2009affected the work of intensive care units in NSW. [370]
Lessons from the NSW laboratory response to pandemic (H1N1) 2009 influenza.[372]
Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW. [374]
Responding to pandemic (H1N1) 2009 influenza in Aboriginal communities in NSWthrough collaboration between NSW Health and the Aboriginalcommunity-controlled health sector. [376]
Reflections on public health surveillance of pandemic (H1N1) 2009 influenza inNSW. [378]
An influenza prophylaxis clinic in a primary school: 24 hours from notificationto protection. [380]
Isolation and quarantine during pandemic (H1N1) 2009 influenza in NSW: theoperational experience of public health units. [382]
Pandemic (H1N1) 2009 influenza in NSW: an overview of the public healthresponse. [384]
Immunogenicity of avian H5N1 influenza virus recombinant vaccines in cats.[386]
Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.[388]
Analyses of the specificity of CD4 T cells during the primary immune responseto influenza virus reveals dramatic MHC-linked asymmetries in reactivity toindividual viral proteins. [390]
New tests for an old foe: an update on influenza screening. [392]
Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis)infected with highly pathogenic avian influenza A (H5N1) virus. [394]
Viral fusion: how Flu induces dimples on liposomes. [396]
Perception and acceptance of intradermal influenza vaccination: Patientreported outcomes from phase 3 clinical trials. [398]
Immunogenicity, large scale safety and lot consistency of an intradermalinfluenza vaccine in adults aged 18-60 years: Randomized, controlled, phase IIItrial. [400]
Influenza A infection triggers thrombotic thrombocytopenic purpura by producingthe anti-ADAMTS13 IgG inhibitor. [402]
High Titers of Hemagglutination Inhibition Antibodies against 2009 H1N1Influenza Virus in Southern Iran. [404]
Financial effects of the highly pathogenic avian influenza outbreaks on theTurkish broiler producers. [406]
Quality of care among obese patients. [408]
Should we "rescue" patients with 2009 influenza A(H1N1) and lung injury fromconventional mechanical ventilation? [410]
Vaccines with MF59 adjuvant expand the antibody repertoire to target protectivesites of pandemic avian H5N1 influenza virus. [412]
Seasonal influenza vaccine provides priming for A/H1N1 immunization. [414]
Response network analysis of differential gene expression in human epitheliallung cells during avian influenza infections. [416]
Molecular epidemiology and antigenic analyses of influenza A Viruses H3N2 inTaiwan. [418]
Modeling the viral dynamics of influenza a virus infection. [420]
Satisfying the need for rapid diagnosis of new variant influenza A H1N1. [422]
Safety and immunogenicity of influenza A H1N1 vaccines. [424]
2009 Pandemic H1N1 Influenza Virus Replicates in Human Lung Tissues. [426]
Antibody Responses of Raccoons Naturally Exposed to Influenza A Virus. [428]
Occurrence of Influenza A(H1N1)v Virus in Western Romania in Relationship toInternational Travel. [430]
Multiple Introduction of Asian H5N1 Avian Influenza Virus in Croatia by WildBirds During 2005-2006 and Isolation of the Virus from Apparently HealthyBlack-Headed Gulls (Larus ridibundus). [432]
Tongue swelling complicating management of a ventilated patient with acuterespiratory distress syndrome secondary to novel influenza A (H1N1). [434]
[Contemporary threat of influenza virus infection] [436]
Immunogenicity of three different influenza vaccines against homologous andheterologous strains in nursing home elderly residents. [438]
Functional glycosylation of dystroglycan is crucial for thymocyte developmentin the mouse. [441]
Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versusOseltamivir as Treatment for Children with Influenza Virus Infection. [444]
Safety of Influenza Vaccine Administration in Egg-Allergic Patients. [446]
[The diagnostic value of fluorescence quantitative PCR in screening ofinfluenza A virus.] [448]
[Report of 2 cases of novel influenza A (H1N1) virus infection complicated withpneumonia and hypoxemia.] [450]
[Clinical features of 127 cases of novel influenza A (H1N1) infection in FujianProvince.] [452]
[Clinical experience of successful management of the first human case withsevere influenza A H1N1 virus infection in Guiyang city.] [454]
[Clinical characteristics and analysis of imaging in patients with severeinfluenza A H1N1 virus infection.] [456]
[Clinical experience in the treatment of a pregnant woman suffering frominfluenza A H1N1 virus infection associated with acute respiratory distresssyndrome.] [458]
[Clinical analysis of 75 patients with severe influenza A H1N1 in QinghaiProvince.] [460]
[The use of extracorporeal membrane oxygenation in sustaining pulmonaryfunction patients with influenza A H1N1.] [462]
[Eighteen cases of 2009 influenza A H1N1 associated with respiratory failure inadults.] [464]
[Treatment of critically ill influenza A H1N1 patients in plateau region.][466]
[The lung protection strategy under the support of extracorporeal membraneoxygenation in patients suffering from influenza A H1N1.] [468]
A universal long-term flu vaccine may not prevent severe epidemics. [470]
Personal Choice or Evidence-Based Nursing Intervention: Nurses' Decision-Makingabout Influenza Vaccination. [472]
A collaborative approach to meeting the psychosocial needs of children duringan influenza pandemic. [474]
Examining the knowledge of and attitudes to pandemic influenza among generalpractice staff. [476]
Use of phylogenetics in the molecular epidemiology and evolutionary studies ofviral infections. [478]
Pandemic influenza: severity must be taken into account. [480]
Quasispecies of the D225G Substitution in the Hemagglutinin of PandemicInfluenza A(H1N1) 2009 Virus from Patients with Severe Disease in Hong Kong,China. [482]
Unexplained increased incidence of Legionnaires disease during the "HeraldWave" of the H1N1 influenza pandemic. [484]
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009influenza virus. [486]
[Identification of a pandemic influenza virus A/H1N1 by real-time PCR] [488]
[Influenza and acute respiratory viral infections. A role of a polyclinictherapist in timely diagnosis and treatment] [490]
[Antiviral activity of sulfated polysaccharide from the brown algae Laminariajaponica against avian influenza A (H5N1) virus infection in the culturedcells] [492]
Establish the habit: influenza vaccination for health care personnel. [494]
Consultation with health care professionals and influenza immunization amongwomen in contact with young children. [496]
Another Nightmare After Sars: Knowledge Perceptions of and OvercomingStrategies for H1N1 Influenza Among Chronic Renal Disease Patients in HongKong. [498]
RESPIRATORY VIRUSES IN ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA. [500]
Limited compatibility of polymerase subunit interactions in influenza A and Bviruses. [502]
Pandemic H1N1 Influenza in the Pediatric Emergency Department: A ComparisonWith Previous Seasonal Influenza Outbreaks. [504]
Impact of oseltamivir treatment on the incidence and course of acute otitismedia in children with influenza. [506]
Characteristics of US public schools with reported cases of novel influenza A(H1N1). [508]
Characterization of two low pathogenic avian influenza viruses isolated inHungary in 2007. [510]
Increasing influenza vaccination rates: Where is the behaviour change theory?[512]
Validation of a method for preparing influenza H5N1 simulated samples. [514]
Influenza virus infection in multinucleated skeletal myofibers. [516]
Characterization of the interaction of influenza virus NS1 with Akt. [518]
Etiology of bronchiolitis in a hospitalized pediatric population: Prospectivemulticenter study. [520]
[Frequency of adverse reactions after influenza vaccination in health carepersonnel of a university hospital in Spain.] [522]
Development of a multiplex real-time RT-PCR assay for detection of influenza A,influenza B, RSV and typing of the 2009-H1N1 influenza virus. [524]
A protein chip designed to differentiate visually antibodies in chickens whichwere infected by four different viruses. [526]
The non-structural (NS1) protein of influenza A virus associates with p53 andinhibits p53-mediated transcriptional activity and apoptosis. [528]
[Review on the etiological property of the swine influenza virus] [530]
[Laboratory confirmation of the first influenza A (H1N1) imported case inMainland China] [532]
[Establishment of a method for rapid detection of the nucleic acid of the novelA (H1N1) influenza virus] [534]
Evaluation of the efficacy of a specific hyperimmune serum in experimentalinfluenza infection in mice. [536]
Deaths: leading causes for 2005. [537]
An anti-influenza component of the bark of Alnus japonica. [539]
Total synthesis of (+)-stachyflin: a potential anti-influenza A virus agent.[541]
Estimating the disease burden of pandemic (H1N1) 2009 virus infection in HunterNew England, Northern New South Wales, Australia, 2009. [543]
Contribution of company affiliation and social contacts to risk estimates ofbetween-farm transmission of avian influenza. [546]
Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccinationcoverage - United States, October 2009-January 2010. [549]
Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenzavaccination coverage among health-care personnel - United States, August2009-January 2010. [551]
[Impact on the population of media campaigns on the influenza H1N1A pandemic.Incidence on the act of shaking hands on saying goodbye, in a rural healthcentre.] [553]
A novel mitogen fusion protein against CD40(+) cells with potent vaccineadjuvant properties. [555]
Accuracy of online health information about controlling childhood fever duringthe H1N1 influenza pandemic. [557]
Non-invasive ventilation in acute respiratory failure related to 2009 pandemicInfluenza A/H1N1 virus infection. [559]
 
Research Articles Abstracts - April 23 2010 Issue

Research Articles Abstracts - April 23 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - April 23 2010 Issue


  1. Mayor S.
    • Department of Health agrees deal with GSK to cancel part of swine flu vaccine order.
    • BMJ. 2010;340:c1946.
    • PubMed
  2. Watson R.
    • WHO is accused of "crying wolf" over swine flu pandemic.
    • BMJ. 2010;340:c1904.
    • PubMed
  3. Kim SH, Samal S.
    • Inhibition of Host Innate Immune Responses and Pathogenicity of Recombinant Newcastle Disease Viruses Expressing NS1 Genes of Influenza A Viruses.
    • J Gen Virol. 2010.
    • PubMed
    • Abstract available
  4. Dimenna L, Latimer B, Parzych E, Haut LH, et al.
    • Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway.
    • J Immunol. 2010.
    • PubMed
    • Abstract available
  5. Campbell AP, Chien JW, Kuypers J, Englund JA, et al.
    • Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.
    • J Infect Dis. 2010;201:1404-13.
    • PubMed
    • Abstract available
  6. Lynfield R.
    • Lessons from Queens.
    • J Infect Dis. 2010;201:973-5.
    • PubMed
  7. Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, et al.
    • Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected by Influenza A Virus.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  8. Soubies SM, Volmer C, Croville G, Loupias J, et al.
    • Species-specific Contribution of the Four C-terminal Amino Acids of Influenza A NS1 Protein to Virulence.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  9. Lin YP, Gregory V, Collins P, Kloess J, et al.
    • Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses due to Substitution of Aspartic acid 151 in the Catalytic Site - Role in Virus Attachment?
    • J Virol. 2010.
    • PubMed
    • Abstract available
  10. Tu W, Mao H, Zheng J, Liu Y, et al.
    • Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-react against 2009 Pandemic H1N1 Influenza Virus.
    • J Virol. 2010.
    • PubMed
    • Abstract available
  11. Siston AM, Rasmussen SA, Honein MA, Fry AM, et al.
    • Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
    • JAMA. 2010;303:1517-25.
    • PubMed
    • Abstract available
  12. Huang WT, Chuang JH, Kuo SH.
    • Monitoring the safety of pandemic H1N1 vaccine.
    • Lancet. 2010;375:1164.
    • PubMed
  13. Destefano F, Tokars J.
    • H1N1 vaccine safety monitoring: beyond background rates.
    • Lancet. 2009.
    • PubMed
  14. # ...
    • Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine.
    • MMWR Morb Mortal Wkly Rep. 2010;59:423-30.
    • PubMed
    • Abstract available
  15. Liljebjelke KA, Petkov DI, Kapczynski DR.
    • Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  16. Prieto-Lara E, Mendez AL.
    • Safety and immunogenicity of prepandemic H5N1 influenza vaccines: A systematic review of the literature.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  17. Chen Z, Zhou H, Jin H.
    • The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  18. Stephenson I, Hayden F, Osterhaus A, Howard W, et al.
    • Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  19. Song JY, Cheong HJ, Hwang IS, Choi WS, et al.
    • Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  20. Abed Y, Simon P, Boivin G.
    • Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation.
    • Antimicrob Agents Chemother. 2010.
    • PubMed
    • Abstract available
-
------
 
Research Articles Abstracts - April 30, 2010 Issue

Research Articles Abstracts - April 30, 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - April 30, 2010 Issue



  1. Ison MG, de Jong MD, Gilligan KJ, Higgs ES, et al.
    • End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  2. Langley JM, Frenette L, Ferguson L, Riff D, et al.
    • Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
  3. Steinhoff MC, Omer SB, Roy E, Arifeen SE, et al.
    • Influenza immunization in pregnancy -- antibody responses in mothers and infants.
    • N Engl J Med. 2010;362:1644-6.
    • PubMed
  4. Valleron AJ, Cori A, Valtat S, Meurisse S, et al.
    • Transmissibility and geographic spread of the 1889 influenza pandemic.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
  5. Brown KF, Kroll JS, Hudson MJ, Ramsay M, et al.
    • Omission bias and vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination programme.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  6. Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, et al.
    • The immunogenicity of intradermal influenza vaccination in COPD patients.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  7. Flasterstein OE, Samira S, Rochlin E, Balasingam S, et al.
    • Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
  8. Rossi GA, Silvestri M, Lanari M.
    • Should the American Academy of Pediatrics respiratory syncytial virus guidelines be modified?
    • Pediatrics. 2010;125:e1021.
    • PubMed
-
------
 
Back
Top